BONNEY MICHAEL W
Insider CIK 1219016 · ALNY Executive Chair, Director · IMUX Director · BMY Director · SYRS Director · THQ Director · GBT Director · THW Director · MGTA Director · AUTL Director · KLDO Executive Chair, Director · HQH Director · CELG Director · SRPT Director · HQL Director · NPSP Director · CBST President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 31,667 | — | $0 | 31,667 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-06-29 | 2026-06-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-18 | 2025-08-19 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-18 | 2025-08-19 | 11,250 | $70.20 | $789.8K | 28,054 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 11,250 | $450.00 | $5.06M | 16,804 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-05-15 | 2025-05-19 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 549 | $267.14 | $146.7K | 27,505 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 245 | $269.79 | $66.1K | 26,531 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 729 | $268.56 | $195.8K | 26,776 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-05-15 | 2025-05-19 | 11,250 | $131.21 | $1.48M | 28,054 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 431 | $271.68 | $117.1K | 26,100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 660 | $273.16 | $180.3K | 25,440 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 1,617 | $283.83 | $459.0K | 16,804 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 1,728 | $282.81 | $488.7K | 18,421 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 802 | $282.03 | $226.2K | 20,149 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 372 | $281.10 | $104.6K | 20,951 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 432 | $280.03 | $121.0K | 21,323 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 1,239 | $278.01 | $344.5K | 21,755 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 1,263 | $277.16 | $350.1K | 22,994 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 301 | $275.63 | $83.0K | 24,257 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-15 | 2025-05-19 | 882 | $273.75 | $241.4K | 24,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-05-08 | 2025-05-12 | 1,558 | — | $0 | 1,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-05-08 | 2025-05-12 | 775 | — | $0 | 16,804 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-12-27 | 2023-12-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-12-27 | 2023-12-29 | 30,000 | $96.45 | $2.89M | 46,029 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-12-27 | 2023-12-29 | 30,000 | $195.00 | $5.85M | 16,029 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 1,389 | $187.04 | $259.8K | 16,479 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 1,535 | $184.89 | $283.8K | 19,582 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 300 | $181.08 | $54.3K | 22,177 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 500 | $182.45 | $91.2K | 21,677 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 560 | $183.75 | $102.9K | 21,117 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 450 | $187.71 | $84.5K | 16,029 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-03 | 2023-08-04 | 1,714 | $185.99 | $318.8K | 17,868 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-08-02 | 2023-08-04 | 22,477 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-08-02 | 2023-08-04 | 22,477 | — | $0 | 22,477 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-08-02 | 2021-08-03 | 22,477 | — | $0 | 22,477 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-06-30 | 2021-07-01 | 345 | — | $0 | 9,342 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-06-13 | 2021-06-14 | 902 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-06-13 | 2021-06-14 | 902 | — | $0 | 12,501 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-06-03 | 2021-06-04 | 2,949 | — | $0 | 2,949 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-06-03 | 2021-06-04 | 2,949 | — | $0 | 11,599 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-03-31 | 2021-04-02 | 366 | $63.13 | $23.1K | 8,930 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-02-01 | 2021-02-03 | 3,054 | $62.21 | $190.0K | 8,565 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-12-31 | 2021-01-05 | 372 | $62.03 | $23.1K | 5,468 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-09-30 | 2020-10-02 | 383 | $60.29 | $23.1K | 5,057 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-06-30 | 2021-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-06-30 | 2020-07-02 | 392 | $58.80 | $23.1K | 4,639 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-14 | 2020-06-16 | 558 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-14 | 2020-06-16 | 558 | — | $0 | 8,650 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-13 | 2020-06-16 | 903 | — | $0 | 902 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-13 | 2020-06-16 | 903 | — | $0 | 8,092 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-03 | 2020-06-05 | 2,949 | — | $0 | 5,898 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-03 | 2020-06-05 | 2,949 | — | $0 | 7,189 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-03-31 | 2020-04-02 | 414 | $55.74 | $23.1K | 4,215 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-02-28 | 3,685 | — | $0 | 3,685 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2020-02-28 | 2020-02-28 | 2,075 | — | $0 | 9,126 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-02-01 | 2020-02-04 | 3,018 | $62.95 | $190.0K | 3,801 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-12-31 | 2020-01-03 | 126 | $64.19 | $8.1K | 782 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | P Buy | 2019-12-04 | 2020-06-09 | 88 | $58.90 | $5.2K | 7,189 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 13,266 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,756 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 970 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 300 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 11,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-22 | 656 | $56.41 | $37.0K | 656 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 19,635 | — | $0 | 19,635 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 1,805 | — | $0 | 1,805 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 558 | — | $0 | 558 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 24,674 | — | $0 | 24,674 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 8,847 | — | $0 | 8,847 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 20,460 | — | $0 | 20,460 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 18,700 | — | $0 | 18,700 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 18,700 | — | $0 | 18,700 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 2,209 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 2,000 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award | 2019-11-20 | 2019-11-27 | 4,069 | — | $0 | 4,069 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award | 2019-11-20 | 2019-11-27 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2019-09-09 | 2019-09-09 | 2,000 | $86.74 | $173.5K | 7,051 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 2,209 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 300 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 1,834 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 970 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 1,534 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-06-03 | 2019-06-05 | 4,756 | — | $0 | 4,756 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2019-03-04 | 2019-03-04 | 3,213 | — | $0 | 3,213 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-04 | 450,000 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-04 | 835,347 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2019-03-04 | 2019-03-04 | 1,633 | — | $0 | 5,051 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-04 | 225,000 | — | $0 | 225,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-04 | 417,673 | — | $0 | 1,426,196 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-02-28 | 2019-03-04 | 2,555 | $14.65 | $37.4K | 1,008,523 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-02-28 | 2019-03-04 | 68,965 | $13.95 | $962.1K | 1,005,968 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 6,429 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 50,025 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 21,847 | — | $0 | 215,346 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 375 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 1,050 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 600 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 13,000 | — | $0 | 13,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 675 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 1,454 | — | $0 | 1,454 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 13,266 | — | $0 | 13,266 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-03-05 | 2018-03-07 | 4,820 | — | $0 | 4,820 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2018-03-05 | 2018-03-07 | 3,418 | — | $0 | 3,418 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-12-04 | 2017-12-05 | 16,400 | — | $0 | 16,400 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 750 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 375 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 900 | — | $0 | 900 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 1,125 | — | $0 | 1,125 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2016-03-09 | 2016-03-10 | 2,000 | $58.36 | $116.7K | 4,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | P Buy | 2016-03-03 | 2016-03-04 | 2,000 | $103.01 | $206.0K | 2,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-02-08 | 2016-02-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| THW Tekla World Healthcare Fun | P Buy | 2015-08-17 | 2015-08-18 | 10,917 | $18.35 | $200.3K | 10,917 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-06-17 | 2015-06-19 | 1,000 | — | $0 | 1,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-06-17 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2015-05-12 | 2015-05-13 | 2,000 | $112.16 | $224.3K | 2,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 36,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,816 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 167,608 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 13,900 | $46.00 | $639.4K | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 3,816 | — | $0 | 3,816 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 19,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 175,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 8,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 135,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 150,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 150,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 125,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 184,044 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 60,096 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 140,550 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 37,389 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 100,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 80,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 200,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 176,226 | $102.00 | $17.98M | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 6,816 | $102.00 | $695.2K | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 600 | $102.00 | $61.2K | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-01-15 | 2015-01-16 | 384 | — | $0 | 167,608 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-12-17 | 2014-12-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-10-15 | 2014-10-17 | 701 | — | $0 | 167,224 | SEC↗ |
| THQ Tekla Healthcare Opportuni | P Buy | 2014-07-28 | 2014-07-29 | 5,000 | $20.00 | $100.0K | 5,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-07-15 | 2014-07-17 | 625 | — | $0 | 166,523 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-06-30 | 2014-07-02 | 367 | $57.87 | $21.2K | 176,226 | SEC↗ |
| HQH H&Q HEALTHCARE INVESTORS | X Exercise deriv | 2014-06-24 | 2014-06-30 | 1,606 | — | $0 | 0 | SEC↗ |
| HQL H&Q LIFE SCIENCES INVESTOR | X Exercise deriv | 2014-06-24 | 2014-06-30 | 2,077 | — | $0 | 0 | SEC↗ |
| HQH H&Q HEALTHCARE INVESTORS | X Exercise | 2014-06-24 | 2014-06-30 | 1,102 | $25.04 | $27.6K | 1,860 | SEC↗ |
| HQL H&Q LIFE SCIENCES INVESTOR | X Exercise | 2014-06-24 | 2014-06-30 | 1,459 | $19.75 | $28.8K | 2,388 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-15 | 2014-05-15 | 3,036 | $67.50 | $204.9K | 175,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-14 | 2014-05-15 | 6,250 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-14 | 3,840 | $69.00 | $265.0K | 172,645 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-14 | 2014-05-15 | 6,250 | — | $0 | 178,895 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-13 | 2014-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-13 | 2014-05-14 | 8,000 | — | $0 | 176,485 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-04-15 | 2014-04-17 | 748 | — | $0 | 165,898 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-03-31 | 2014-04-02 | 213 | $73.15 | $15.6K | 6,816 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-27 | 2014-02-28 | 100,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-27 | 2014-02-28 | 100,000 | $10.84 | $1.08M | 268,485 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-27 | 2014-02-28 | 100,000 | $81.25 | $8.13M | 168,485 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-20 | 2014-02-21 | 3,112 | $75.60 | $235.3K | 168,485 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-19 | 2014-02-21 | 9,500 | — | $0 | 19,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-19 | 2014-02-21 | 9,500 | — | $0 | 171,597 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 140,550 | — | $0 | 140,550 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 37,389 | — | $0 | 37,389 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 4,572 | — | $0 | 165,150 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-01-15 | 2014-01-15 | 490 | — | $0 | 160,578 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-10-15 | 2013-10-16 | 621 | — | $0 | 160,088 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-07-15 | 2013-07-16 | 987 | — | $0 | 159,467 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-06-28 | 2013-07-02 | 579 | $36.69 | $21.2K | 162,097 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-20 | 2013-05-22 | 60,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-20 | 2013-05-22 | 60,000 | $50.00 | $3.00M | 161,518 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-20 | 2013-05-22 | 60,000 | $12.61 | $756.6K | 221,518 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-16 | 2013-05-17 | 2,400 | $47.88 | $114.9K | 161,518 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-15 | 2013-05-17 | 5,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-15 | 2013-05-16 | 2,979 | $48.41 | $144.2K | 158,918 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-15 | 2013-05-17 | 5,000 | — | $0 | 163,918 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-14 | 2013-05-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-14 | 2013-05-15 | 3,753 | $49.18 | $184.6K | 155,647 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-14 | 2013-05-16 | 6,250 | — | $0 | 161,897 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-13 | 2013-05-15 | 8,000 | — | $0 | 16,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-13 | 2013-05-15 | 8,000 | — | $0 | 159,400 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-04-15 | 2013-04-17 | 1,474 | — | $0 | 158,480 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-03-28 | 2013-04-02 | 326 | $46.82 | $15.3K | 6,603 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-02-19 | 2013-02-20 | 9,500 | — | $0 | 28,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-02-19 | 2013-02-20 | 9,500 | — | $0 | 152,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 184,044 | — | $0 | 184,044 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 60,096 | — | $0 | 60,096 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 15,188 | — | $0 | 157,006 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-02-07 | 2013-02-11 | 5,325 | $8.74 | $46.5K | 13,900 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 15,225 | — | $0 | 19,225 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-01-29 | 2013-01-30 | 65,100 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-01-29 | 2013-01-30 | 65,100 | $42.85 | $2.79M | 142,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-01-29 | 2013-01-30 | 65,100 | $8.23 | $535.8K | 207,600 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-01-28 | 2013-01-30 | 40,352 | — | $0 | 65,100 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-01-28 | 2013-01-30 | 40,352 | $8.23 | $332.1K | 182,852 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-01-28 | 2013-01-30 | 40,352 | $43.09 | $1.74M | 142,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-06-29 | 2012-07-03 | 640 | $32.22 | $20.6K | 142,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-16 | 2012-05-16 | 2,098 | $41.85 | $87.8K | 147,877 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-15 | 2012-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 2,147 | $41.90 | $90.0K | 149,975 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-15 | 2012-05-16 | 5,000 | — | $0 | 152,122 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 6,250 | — | $0 | 12,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-05-15 | 2,927 | $41.55 | $121.6K | 140,872 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 6,250 | — | $0 | 147,122 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-13 | 2012-05-15 | 8,000 | — | $0 | 24,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-13 | 2012-05-15 | 8,000 | — | $0 | 143,799 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-03-30 | 2012-04-03 | 260 | $43.25 | $11.2K | 135,799 | SEC↗ |
| HQL H&Q LIFE SCIENCES INVESTOR | P Buy | 2012-03-09 | 2012-03-12 | 800 | $13.25 | $10.6K | 800 | SEC↗ |
| HQH H&Q HEALTHCARE INVESTORS | P Buy | 2012-03-09 | 2012-03-12 | 650 | $15.80 | $10.3K | 650 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-19 | 2012-02-21 | 38,000 | — | $0 | 38,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-19 | 2012-02-21 | 200,000 | $42.09 | $8.42M | 200,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 15,225 | — | $0 | 15,225 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-17 | 2012-01-19 | 2,278 | — | $0 | 141,818 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2011-12-30 | 2012-01-04 | 106 | $30.80 | $3.3K | 135,539 | SEC↗ |